Service Incident: New DOI registrations are working again. Re-registration of failed DOI registrations (~500) are still affected by the service incident at DataCite (our DOI registration agency).
Published June 30, 2019 | Version v1
Journal article Open

REVIEW ON BIOMARKERS: TOOL FOR DIAGNOSIS OF A DISEASE AND DRUG DEVELOPMENT

  • 1. Kasturi Shikshan Sanstha's College of Pharmacy, Shikrapur, Pune-412207, Maharashtra, India.

Description

Biomarker measurements have become an essential component of oncology drug development, particularly so in this era of targeted therapies. Such measurements ensure that clinical studies are testing our biological hypotheses and can help make the difficult decisions required to choose which drugs to stop developing or de-prioritise. In this review we discuss the intrinsic properties of biological sample based efficacy measurements and how these relate to their implementation in oncology drug development by way of points to consider and examples. In short use of biomarker data will help us make the best possible use of precious human samples and maximize the chances of success of the most promising therapeutic approaches.

Files

190520.pdf

Files (841.1 kB)

Name Size Download all
md5:4acd3ee4330b598529b0cc7ec5af7885
841.1 kB Preview Download